ClinicalTrials.govpublic full text
Alvocidib in Combination With Decitabine and Venetoclax in Patients With Relapsed or Refractory AML or as Frontline Therapy in Unfit Patients With AML
recurrent acute myeloid leukemia, refractory acute myeloid leukemia, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 860266
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.